Fig. 1 · Structure

Documents & Downloads

Mal-GGFG-PAB-MMAE

Drug-Linker Conjugate

Mal-GGFG-PAB-MMAE is a drug-linker conjugate designed for targeted cancer therapy. Comprising the mitotic inhibitor MMAE linked via Mal-GGFG-PAB, this compound facilitates the selective delivery of cytotoxic agents to tumor cells. It is primarily utilized in the synthesis of antibody-drug conjugates, enhancing therapeutic efficacy while minimizing off-target effects.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 3055607-18-3
Applications Drug-Linker Conjugate
Formula C69H97N11O16
Molecular Weight 1336.57
SMILES
O[C@@H](C1=CC=CC=C1)[C@@H](C)NC([C@H](C)[C@H]([C@@]2([H])N(CCC2)C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCC3=CC=C(C=C3)NC(CNC([C@@H](NC(CNC(CNC(CCN4C(C=CC4=O)=O)=O)=O)=O)CC5=CC=CC=C5)=O)=O)=O)=O)=O)=O)OC)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...